3. BLOOD GLUCOSE HOMEOSTASIS
?Blood glucose level is tightly controlled because the
brain constantly needs glucose
?Severe hypoglycemia can cause coma and death
?Chronic hyperglycemia results in
?Glycation of proteins,
?Endothelial dysfunction
?Diabetes
7. FACTORS MAINTAINING BLOOD GLUCOSE
Factors which cause entry of
glucose into blood
? Absorption from intestines
? Glycogenolysis
? Gluconeogenesis
? Hyperglycemic hormones
Factors leading to depletion
of glucose in blood
? Utilization by tissues for
energy
? Glycogen synthesis
? Conversion of glucose into
fat
? Hypoglycemic hormone
11. HORMONAL REGULATION
The pancreas
detects the
change in blood
glucose
concentration
and releases the
appropriate
hormone
High blood
glucose
Signal to
release
Hypoglycemic
hormone
insulin
Low blood
glucose
Signal to
release
Hyperglycemic
hormone
glucagon
12. HYPERGLYCEMIC HORMONES
GLUCAGON Promotes Glycogenolysis, gluconeogenesis
Depresses glycogen synthesis
EPINEPHRINE Promotes Glycogenolysis, gluconeogenesis
Favours uptake of amino acids
CORTISOL Increases gluconeogenesis
Releases amino acids from the muscle
GROWTH
HORMONE
Decreases glycolysis
Mobilizes fatty acids from adipose tissue
16. HORMONAL REGULATION- INSULIN
? Glucose is diffused into cells through
transporters such as GLUT4
? GLUT4 is present in cytoplasmic
vesicles
? Insulin binding to its receptor causes
vesicles to diffuse into plasma
membrane
? Brain and liver have non-insulin
dependent glucose transporter
21. BLOOD GLUCOSE C CLINICAL ASPECT
Estimation
Common
terms
Value
interpretaio
n
22. BLOOD GLUCOSE ESTIMATION
? The blood is collected using an anticoagulant (potassium
oxalate) and an inhibitor of glycolysis (sodium fluoride).
? Fluoride inhibits the enzyme, enolase, and so glycolysis on
the whole is inhibited
? The glucose oxidase (GOD) method is the one most widely
used.
23. NORMAL VALUES- common terms
? A FBS is taken after at least eight
hours of fasting
FASTING PLASMA
GLUCOSE [FPG/FBS]
? Test done any time of day without
regard to time since last meal.
RANDOM PLASMA
GLUCOSE [RBS/RPG]
? The test done about 2 hr after a good
meal
POST-PRANDIAL
BLOOD GLUCOS
[PPBS]
#26: Recommendation 6
The oral glucose tolerance test (OGTT) should be retained as a diagnostic
test for the following reasons
fasting plasma glucose alone fails to diagnose approximately 30% of
cases of previously undiagnosed diabetes
an OGTT is the only means of identifying people with IGT
an OGTT is frequently needed to confirm or exclude an abnormality
of glucose tolerance in asymptomatic people
An OGTT should be used in individuals with fasting plasma glucose
6.1C6.9mmol/l (110C125mg/dl) to determine glucose tolerance status.
Recommendation 7
Currently HbA1c is not considered a suitable diagnostic test for diabetes
or intermediate hyperglycaemia.
#27: Federation of Clinical Chemistry (IFCC) recommendation that all glucose
measuring devices report in plasma values57.
Measurement differences may also arise depending on the site of collection
of the blood sample. Venous and capillary samples will give the same
result in the fasting state but in the non-fasting state capillary will give
higher results than venous samples.
The processing of the sample after collection is important to ensure accurate
measurement of plasma glucose. This requires rapid separation of
the plasma after collection (within minutes) but it is recognised that this
seldom occurs. Collection into a container with glycolytic inhibitors (eg
NaF) is only partially effective. A minimum requirement is that the sample
should be placed immediately in ice-water after collection and before
separating but even so separation should be within 30min58.
Recommendation 5 1. Venous plasma glucose should be the standard method for measuring
and reporting. However in recognition of the widespread use of capillary
sampling, especially in under-resourced countries, conversion
values for capillary plasma glucose are provided for post- load glucose
values. Fasting values for venous and capillary plasma glucose are
identical.
2. Glucose should be measured immediately after collection by near
patient testing, or if a blood sample is collected, plasma should
be immediately separated, or the sample should be collected into
a container with glycolytic inhibitors and placed on ice-water until
separated prior to analysis.
#28: National Glycohemoglobin Standardization
Program (NGSP) and standardized
or traceable to the Diabetes Control
and Complications Trial (DCCT)